ConductScience.org, home

Paper42932136PubMed

Skeletal Muscle in Vulnerable Populations Receiving Cardiorenal-Metabolic Therapies: SGLT2 Inhibitors, Incretin-Based Therapies, and the Challenge of Precision Medicine.

Koufakis T and 6 others. Adv Ther, 2026.

Cite this record

ConductScience Library. Skeletal Muscle in Vulnerable Populations Receiving Cardiorenal-Metabolic Therapies: SGLT2 Inhibitors, Incretin-Based Therapies, and the Challenge of Precision Medicine. Papers, record 42932136. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42932136

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Skeletal Muscle in Vulnerable Populations Receiving Cardiorenal-Metabolic Therapies: SGLT2 Inhibitors, Incretin-Based Therapies, and the Challenge of Precision Medicine.
Journal
Adv Ther
Year
2026
Publication types
Journal Article, Review
Revised in PubMed
2026-10-26

Source PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Koufakis TTheocharishttps://orcid.org/0000-0002-5853-1352
2Tentolouris AAnastasios
3Manthou EEleni
4Teperikidis LLefteris
5Mylonas AAndreas
6Kotsa KKalliopi
7Doumas MMichael

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References81

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
132940941Role of Skeletal Muscle in Insulin Resistance and Glucose Uptake.Compr Physiol2020https://conductscience.org/library/papers/32940941PubMed
241744761Decoding the Endocrine Code of Skeletal Muscle: Myokines, Exerkines, and Inter-Organ Crosstalk in Metabolic Health and Disease.Cells2026https://conductscience.org/library/papers/41744761PubMed
337186680Sarcopenia and Cardiovascular Diseases.Circulation2023https://conductscience.org/library/papers/37186680PubMed
441465572Sarcopenia in the Aging Process: Pathophysiological Mechanisms, Clinical Implications, and Emerging Therapeutic Approaches.Int J Mol Sci2025https://conductscience.org/library/papers/41465572PubMed
542183678Beyond sarcopenia and frailty: the underrecognised contribution of adiposity to vulnerability in older adults.Acta Cardiol2026https://conductscience.org/library/papers/42183678PubMed
636292489Approaching Sarcopenic Obesity in Young and Middle-Aged Female Adults in Weight Management Settings: A Narrative Review.Healthcare (Basel)2022https://conductscience.org/library/papers/36292489PubMed
732082422Mechanism of increased risk of insulin resistance in aging skeletal muscle.Diabetol Metab Syndr2020https://conductscience.org/library/papers/32082422PubMed
839796218Mitochondria and the Repurposing of Diabetes Drugs for Off-Label Health Benefits.Int J Mol Sci2025https://conductscience.org/library/papers/39796218PubMed
941354946Effectiveness of SGLT2 inhibitors, incretin-based therapies, and finerenone on cardiorenal outcomes: a meta-analysis and network meta-analysis.Cardiovasc Diabetol Endocrinol Rep2025https://conductscience.org/library/papers/41354946PubMed
1036882248Efficacy and safety of GLP-1 receptor agonists versus SGLT-2 inhibitors in overweight/obese patients with or without diabetes mellitus: a systematic review and network meta-analysis.BMJ Open2023https://conductscience.org/library/papers/36882248PubMed
1141201615Muscle loss and GLP-1R agonists use.Acta Diabetol2026https://conductscience.org/library/papers/41201615PubMed
1242339604Effects of sodium-glucose cotransporter 2 inhibitors on body weight and metabolic parameters in obese patients with and without type 2 diabetes: a systematized narrative review.Curr Med Res Opin2026https://conductscience.org/library/papers/42339604PubMed
1341419185A Meta-Analysis of Body Composition Changes Associated With Long-term Use of Sodium-Glucose Cotransporter 2 Inhibitors.Endocr Pract2026https://conductscience.org/library/papers/41419185PubMed
1436584211Effect of SGLT-2 inhibitors on body composition in patients with type 2 diabetes mellitus: A meta-analysis of randomized controlled trials.PLoS One2022https://conductscience.org/library/papers/36584211PubMed
1534120150Dapagliflozin increases the lean-to total mass ratio in type 2 diabetes mellitus.Nutr Diabetes2021https://conductscience.org/library/papers/34120150PubMed
1639768974Effects of Sodium-Glucose Cotransporter-2 Inhibitors on Body Composition and Fluid Status in Cardiovascular Rehabilitation Patients with Coronary Artery Disease and Heart Failure.Medicina (Kaunas)2024https://conductscience.org/library/papers/39768974PubMed
1740630104SGLT2 inhibitors as metabolic modulators: beyond glycemic control in type 2 diabetes.Front Endocrinol (Lausanne)2025https://conductscience.org/library/papers/40630104PubMed
1840810125Exploring the disconnect: mechanisms underpinning the absence of physical function improvement with SGLT2 inhibitors.Front Syst Biol2025https://conductscience.org/library/papers/40810125PubMed
1932580152Improvement of skeletal muscle insulin sensitivity by 1 week of SGLT2 inhibitor use.Endocr Connect2020https://conductscience.org/library/papers/32580152PubMed
2034854254Extracellular lipidome change by an SGLT2 inhibitor, luseogliflozin, contributes to prevent skeletal muscle atrophy in db/db mice.J Cachexia Sarcopenia Muscle2022https://conductscience.org/library/papers/34854254PubMed

See all 81 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42932136

GET https://conductscience.org/api/papers/v1/42932136/references?page=2